Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Area of Science:

• Cardiology
• Medical Devices

Background:

• The benefit of implantable cardioverter-defibrillators (ICDs) is established for systolic heart failure due to coronary artery disease.
• Evidence for ICDs in non-coronary systolic heart failure relies on subgroup analyses, with limited data on contemporary management including cardiac resynchronization therapy (CRT).

Purpose of the Study:

• To evaluate the efficacy of prophylactic ICD implantation in patients with symptomatic systolic heart failure not caused by coronary artery disease.
• To assess the impact of ICDs on all-cause mortality, sudden cardiac death, and cardiovascular death in this specific patient population.

Main Methods:

• A randomized controlled trial involving 1116 patients with symptomatic systolic heart failure (left ventricular ejection fraction ≤35%) not due to coronary artery disease.
• Patients were assigned to either ICD implantation or usual clinical care, with 58% in both groups receiving cardiac resynchronization therapy (CRT).
• Primary outcome was death from any cause; secondary outcomes included sudden cardiac death and cardiovascular death.

Main Results:

• After a median follow-up of 67.6 months, no significant difference in all-cause mortality was observed between the ICD and control groups (21.6% vs. 23.4%, P=0.28).
• A significant reduction in sudden cardiac death was observed in the ICD group compared to the control group (4.3% vs. 8.2%, P=0.005).
• Device infection rates were similar between the groups (4.9% vs. 3.6%, P=0.29).

Conclusions:

• Prophylactic ICD implantation in patients with systolic heart failure not caused by coronary artery disease did not significantly reduce the long-term rate of death from any cause.
• ICDs demonstrated a significant benefit in reducing sudden cardiac death in this patient cohort.
• The findings suggest that while ICDs may not improve overall survival, they play a crucial role in preventing sudden cardiac death in specific heart failure populations.